tirzepatide
Drug Name | Form | Strength | Formulary Unrestricted | Formulary Restricted | Non-Formulary | Interchange |
---|---|---|---|---|---|---|
Mounjaro | INJECTION, SUBCUTANEOUS | 2.5 mg/0.5mL, 5 mg/0.5mL, 7.5 mg/0.5 mL, 10 mg/0.5 mL, 12.5 mg/0.5mL, 15 mg/0.5mL | ||||
Zepbound | INJECTION, SUBCUTANEOUS | 2.5 mg/0.5 mL, 5 mg/0.5mL, 7.5 mg/0.5 mL, 10 mg/0.5 mL, 12.5 mg/0.5mL, 15 mg/0.5mL |
Inpatients may use home supply.
Reviewed: Jan. 2023 (Mounjaro), May 2024 (Zepbound)
Spotlight Tirzepatide (Mounjaro)
Spotlight Tirzepatide (Zepbound)